A detailed history of Yousif Capital Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 12,850 shares of COLL stock, worth $384,986. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,850
Previous 13,409 4.17%
Holding current value
$384,986
Previous $431,000 15.08%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$31.4 - $39.07 $17,552 - $21,840
-559 Reduced 4.17%
12,850 $496,000
Q2 2024

Jul 31, 2024

SELL
$31.36 - $39.99 $46,569 - $59,385
-1,485 Reduced 9.97%
13,409 $431,000
Q1 2024

Apr 26, 2024

SELL
$31.23 - $40.91 $104,839 - $137,334
-3,357 Reduced 18.39%
14,894 $578,000
Q4 2023

Feb 01, 2024

SELL
$21.16 - $30.8 $15,150 - $22,052
-716 Reduced 3.77%
18,251 $561,000
Q3 2023

Oct 30, 2023

SELL
$21.23 - $24.28 $19,850 - $22,701
-935 Reduced 4.7%
18,967 $423,000
Q2 2023

Aug 02, 2023

SELL
$21.06 - $24.0 $17,564 - $20,016
-834 Reduced 4.02%
19,902 $427,000
Q1 2023

May 02, 2023

SELL
$23.0 - $29.88 $55,430 - $72,010
-2,410 Reduced 10.41%
20,736 $497,000
Q4 2022

Jan 09, 2023

SELL
$16.14 - $23.55 $133,962 - $195,465
-8,300 Reduced 26.39%
23,146 $0
Q3 2022

Nov 04, 2022

SELL
$15.46 - $20.1 $12,739 - $16,562
-824 Reduced 2.55%
31,446 $504,000
Q2 2022

Aug 01, 2022

SELL
$14.22 - $20.88 $43,371 - $63,684
-3,050 Reduced 8.64%
32,270 $572,000
Q1 2022

May 12, 2022

BUY
$17.2 - $22.5 $223 - $292
13 Added 0.04%
35,320 $719,000
Q4 2021

Jan 31, 2022

BUY
$17.5 - $21.35 $617,872 - $753,804
35,307 New
35,307 $660,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.